Blood Tests Detect Body Changes Years Before IBD Diagnosis
Researchers have shown that changes can be detected in blood tests up to eight years before a diagnosis of Crohn’s disease.
Researchers have shown that changes can be detected in blood tests up to eight years before a diagnosis of Crohn’s disease.
Castle Biosciences' Barrett’s Esophagus test can improve management decisions for Barrett’s esophagus patients with low-grade dysplasia.
Molecular biology has been making significant strides in the field of parasitology, and one...
Individuals with a gastrointestinal biopsy still have a heightened risk of IBD following a normal biopsy than their population references.
Read MoreThe AGA now recommends non-invasive biomarkers as a first-line strategy for monitoring many patients with ulcerative colitis.
Read MoreA team of researchers developed a new, non-invasive system to facilitate the diagnosis and treatment of gastrointestinal motility disorders.
Read MoreMaia Gatlin of the Georgia Institute of Technology described how a noninvasive toilet microphone sensor could identify bowel diseases.
Read MoreU.S. Patent 11,493,515 was issued for a noninvasive test that more accurately diagnoses a potentially fatal condition in premature infants.
Read MoreProciseDx Inc. announces it has received FDA clearance for its ProciseDx instrument and C reactive Protein (CRP) test.
Read MoreResearchers have created a method that makes sewage monitoring possible for a virus that may be linked to hepatitis outbreaks worldwide.
Read MorePrometheus Laboratories Inc. is partnering with Takeda to nationally launch CDPATH, a prognostic tool for Crohn’s disease patients.
Read MoreThe new test helps physicians monitor inflammation of the gastrointestinal tract by painlessly collecting samples while the patient is awake.
Read MoreResearch shows that a new route of transmission exists for stomach viruses, which afflict billions of people each year and can be deadly.
Read MoreA simple device, a silicone tube filled with liquid metal and knotted many times, produces results similar to manometry.
Read MoreWhile there are a number of testing options for h. pylori, stool antigen testing offers a better choice due to its accuracy and cost effectiveness.
Read MoreMeridian Bioscience says its Curian Campy assay—an immunoassay for the detection of a Campylobacter-specific antigen—received FDA clearance.
Read MoreResearchers used a novel, highly sensitive test to measure the amount of toxin produced by C. difficile in the stool of patients with suspected infections.
Read MoreOhio Gastroenterology Group, Inc. and Cerebrum Corp. have announced a partnership to enhance the personalization of patient care.
Read More